Romark Alinia Cryptosporidium Indication Expanded To Adults, Teens
This article was originally published in The Pink Sheet Daily
Executive Summary
Supplement receives priority review at FDA; previous indication was in children ages one to 11 years. The firm is looking at future indications in Crohn’s disease and Clostridium difficile-associated diarrhea.